The NSUN6 Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human AGS gastric adenocarcinoma cell line. This product provides a mixed population of cells with targeted disruption of the NSUN6 gene, offering a versatile loss-of-function model for studying RNA methylation and its role in gastric cancer biology. The polyclonal format reflects the heterogeneous nature of the knockout, which is generated without single-cell clonal isolation, ensuring a broad representation of genetic edits within the population. This approach allows researchers to examine the overall impact of NSUN6 ablation in a cellular context that recapitulates the genetic diversity of the original cell line.
AGS cells are a well-characterized human gastric adenocarcinoma cell line derived from a patient with gastric cancer. They serve as a representative model for studying epithelial tumor biology, including gastric cancer cell proliferation, migration, invasion, and tumorigenicity. AGS cells are particularly useful for elucidating signaling mechanisms and epigenetic or epitranscriptomic alterations that drive gastric cancer progression. Their adherent growth and robust maintenance make them compatible with a wide range of standard cell-based assays, enabling high-throughput screening and detailed mechanistic studies. The use of AGS cells as the knockout host therefore provides a clinically relevant platform for investigating the oncogenic mechanisms mediated by RNA modifications.
NSUN6 is an RNA methyltransferase that specifically catalyzes the formation of 5-methylcytosine (m5C) on tRNAs (primarily tRNA-Cys and tRNA-Thr) and selected mRNAs, playing a critical role in epitranscriptomic regulation. This modification influences RNA stability, translation efficiency, and proper tRNA folding, thereby modulating the synthesis of key proteins. NSUN6 is transcriptionally regulated by MYC and is activated by cellular stress signals, linking nutrient sensing and oncogenic programs to RNA modification dynamics. By methylating its substrates, NSUN6 promotes the stability of target mRNAs and facilitates efficient translation, which in turn supports cellular proliferation. Disruption of NSUN6 therefore interrupts these downstream molecular events, impairing the synthesis of proteins necessary for cancer cell growth.
In AGS gastric cancer cells, NSUN6 is implicated in maintaining the malignant phenotype through its role in optimizing the translation of proteins involved in cell cycle progression, survival, and motility. The mechanistic summary provided indicates that NSUN6 knockout abolishes m5C methylation on specific tRNAs and mRNAs, leading to reduced translation of key proteins and potential impairment of gastric cancer cell proliferation and tumorigenicity. This model is therefore highly relevant for studying how aberrant RNA methylation contributes to gastric cancer pathogenesis. By comparing knockout and wild-type AGS cells, researchers can identify NSUN6-dependent translationally regulated targets and assess their functional significance. The polyclonal population ensures that observed phenotypes are robust and not due to clonal artifacts, providing a reliable system for mechanistic discovery.
These knockout cells are ideal for a variety of research applications, including epitranscriptomic studies, gene function analysis, and gastric cancer research. Typical assays include western blotting to confirm loss of NSUN6 protein, RT-qPCR to analyze downstream target mRNA levels, and m5C bisulfite sequencing to map specific RNA methylation changes. Functional assessments can be performed using cell proliferation, migration, and invasion assays to evaluate the impact on tumor cell behavior, while RNA stability assays directly measure the effects on transcript half-life. By employing this NSUN6 knockout model, scientists can uncover new regulatory nodes in RNA modification pathways and identify therapeutic vulnerabilities in gastric cancer. For further details or technical support, please contact Ascent Research.
